CN102818889B - 检测结核杆菌脂阿拉伯甘露聚糖特异性抗体的方法 - Google Patents
检测结核杆菌脂阿拉伯甘露聚糖特异性抗体的方法 Download PDFInfo
- Publication number
- CN102818889B CN102818889B CN201110155264.0A CN201110155264A CN102818889B CN 102818889 B CN102818889 B CN 102818889B CN 201110155264 A CN201110155264 A CN 201110155264A CN 102818889 B CN102818889 B CN 102818889B
- Authority
- CN
- China
- Prior art keywords
- reagent
- lam
- emulsion particle
- antigen
- effluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 241000187479 Mycobacterium tuberculosis Species 0.000 title abstract description 3
- 239000000427 antigen Substances 0.000 claims abstract description 81
- 102000036639 antigens Human genes 0.000 claims abstract description 79
- 108091007433 antigens Proteins 0.000 claims abstract description 79
- 239000002245 particle Substances 0.000 claims abstract description 54
- 239000000839 emulsion Substances 0.000 claims abstract description 47
- 238000001514 detection method Methods 0.000 claims abstract description 44
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 38
- 102100031561 Hamartin Human genes 0.000 claims description 87
- 238000012360 testing method Methods 0.000 claims description 24
- 239000004816 latex Substances 0.000 claims description 23
- 229920000126 latex Polymers 0.000 claims description 23
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 19
- 238000003317 immunochromatography Methods 0.000 claims description 12
- 238000010168 coupling process Methods 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 10
- 238000005859 coupling reaction Methods 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 238000004587 chromatography analysis Methods 0.000 claims description 7
- 210000000481 breast Anatomy 0.000 claims description 6
- 239000003292 glue Substances 0.000 claims description 6
- 239000004531 microgranule Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 238000003149 assay kit Methods 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 201000008827 tuberculosis Diseases 0.000 description 22
- 239000000523 sample Substances 0.000 description 14
- 238000002372 labelling Methods 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 102000008100 Human Serum Albumin Human genes 0.000 description 8
- 108091006905 Human Serum Albumin Proteins 0.000 description 8
- 239000000020 Nitrocellulose Substances 0.000 description 8
- 229920001220 nitrocellulos Polymers 0.000 description 8
- 238000000576 coating method Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000009739 binding Methods 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 239000008366 buffered solution Substances 0.000 description 5
- 238000005325 percolation Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000003365 glass fiber Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 208000036981 active tuberculosis Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102100037170 Phosphate carrier protein, mitochondrial Human genes 0.000 description 1
- 101710128683 Phosphate carrier protein, mitochondrial Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001355 anti-mycobacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000006674 extrapulmonary tuberculosis Diseases 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 238000012092 latex agglutination test Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Substances [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110155264.0A CN102818889B (zh) | 2011-06-09 | 2011-06-09 | 检测结核杆菌脂阿拉伯甘露聚糖特异性抗体的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110155264.0A CN102818889B (zh) | 2011-06-09 | 2011-06-09 | 检测结核杆菌脂阿拉伯甘露聚糖特异性抗体的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102818889A CN102818889A (zh) | 2012-12-12 |
CN102818889B true CN102818889B (zh) | 2017-05-10 |
Family
ID=47303128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110155264.0A Active CN102818889B (zh) | 2011-06-09 | 2011-06-09 | 检测结核杆菌脂阿拉伯甘露聚糖特异性抗体的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102818889B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105092861A (zh) * | 2015-09-14 | 2015-11-25 | 广州市微米生物科技有限公司 | 一种crp/saa定量联合检测免疫荧光层析试纸及其制备方法 |
CN106608907B (zh) * | 2015-10-27 | 2021-08-03 | 中国科学院上海巴斯德研究所 | 抗ERPV-ATIp重组截短蛋白单克隆抗体的制备和应用 |
NL2017204B1 (en) * | 2016-06-08 | 2017-12-18 | Kei International Ltd | Solid substrate comprising antigens immobilised thereto, biosensor comprising said solid substrate and method for detecting the presence of mycobacterial material in a sample |
WO2017211314A1 (en) * | 2016-06-08 | 2017-12-14 | Kei International Limited | Method for detecting presence of mycobacterial material in sample using immobilised mannosyl phosphoketide antigen |
CN110568185B (zh) * | 2019-08-06 | 2022-11-18 | 上海荣盛生物药业股份有限公司 | 脂阿拉伯甘露聚糖检测助剂及其组合物和试剂盒 |
CN110501492B (zh) * | 2019-08-06 | 2022-07-01 | 上海荣盛生物药业股份有限公司 | 脂阿拉伯甘露聚糖检测增敏剂及其组合物和试剂盒 |
CN110568186B (zh) * | 2019-08-06 | 2022-12-16 | 上海荣盛生物药业股份有限公司 | 检测脂阿拉伯甘露聚糖的组分及其试剂盒 |
CN111337665A (zh) * | 2020-01-16 | 2020-06-26 | 卢氏实验室公司 | 一种用于检测肺结核感染的免疫层析试纸条及其制备方法 |
CN111443198A (zh) * | 2020-03-19 | 2020-07-24 | 济南杏恩生物科技有限公司 | 一种基于胶体金法快速检测结核菌分泌蛋白的方法 |
CN114324879B (zh) * | 2021-12-30 | 2022-09-27 | 浙江默乐生物科技有限公司 | 一种基于胶体金双抗夹心法的新型冠状病毒中和抗体定性检测试剂盒 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0921397A1 (en) * | 1997-12-08 | 1999-06-09 | Kreatech Biotechnology B.V. | A method for identifying a mycobacterium species |
EP1659407A1 (en) * | 2004-11-19 | 2006-05-24 | Norwegian Antibodies AS | Diagnostic control system |
CN101140284A (zh) * | 2007-10-16 | 2008-03-12 | 天津中新科炬生物制药有限公司 | 一种结核分枝杆菌抗体快速诊断试剂盒及其检测方法 |
CN101762692A (zh) * | 2009-06-24 | 2010-06-30 | 北京科美东雅生物技术有限公司 | 一种检测tb抗体的磁性免疫层析试纸条及其制备方法 |
-
2011
- 2011-06-09 CN CN201110155264.0A patent/CN102818889B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102818889A (zh) | 2012-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102818889B (zh) | 检测结核杆菌脂阿拉伯甘露聚糖特异性抗体的方法 | |
Smits et al. | Simple latex agglutination assay for rapid serodiagnosis of human leptospirosis | |
Castro et al. | Novel point-of-care test for simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis | |
KR102322094B1 (ko) | 바이러스 및 박테리아 감염의 복합 검출을 위한 방법 및 장치 | |
Murdoch et al. | Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia | |
Marangoni et al. | Evaluation of LIAISON Treponema Screen, a novel recombinant antigen-based chemiluminescence immunoassay for laboratory diagnosis of syphilis | |
JP6150559B2 (ja) | マイコプラズマ・ニューモニアの検出方法 | |
US20120220049A1 (en) | Assay method and device | |
WO2015044453A1 (en) | Diagnostic kits and immunoassay methods for diagnosis and differentiation of african swine fever virus (asfv) and classical swine fever virus (csfv) | |
Mogilyansky et al. | Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease | |
Siev et al. | Correlation between serum and plasma antibody titers to mycobacterial antigens | |
Naidu et al. | Comparative study of Treponemal and non-Treponemal test for screening of blood donated at a blood center | |
Leader et al. | Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum | |
Smits et al. | Development and evaluation of a rapid dipstick assay for serodiagnosis of acute human brucellosis | |
CN101858914B (zh) | 梅毒特异性总抗体胶体金免疫层析检测试剂条及其制备方法 | |
CN105859843A (zh) | 呼吸道合胞病毒抗原制备方法及利用该抗原制备的呼吸道合胞病毒抗体的快速检测试剂盒 | |
CN101825634A (zh) | 梅毒特异性IgM与IgG抗体联合检测试剂条及其制备方法 | |
CN103837680A (zh) | 一种猪hev总抗体elisa检测试剂盒的制备方法 | |
CN101858916A (zh) | 梅毒特异性IgM抗体胶体金免疫层析检测试剂条及其制备方法 | |
Jin et al. | Fast dipstick dye immunoassay for detection of immunoglobulin G (IgG) and IgM antibodies of human toxoplasmosis | |
Khan et al. | Development of a simple, peripheral-blood-based lateral-flow dipstick assay for accurate detection of patients with enteric fever | |
CN101858915A (zh) | 梅毒特异性IgG抗体胶体金免疫层析检测试剂条及其制备方法 | |
CN201673156U (zh) | 梅毒特异性IgM抗体胶体金免疫层析检测试剂条 | |
Vaish et al. | Evaluation of two novel rapid rKE16 antigen-based tests for diagnosis of visceral leishmaniasis in India | |
Harris et al. | Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170629 Address after: 200231, room 317, building 2A, 2715 Wu Long Road, Shanghai, Xuhui District Patentee after: VENTURE BIOTECHNOLOGY CO.,LTD. Address before: 200231, room 2, building 2715, 317 Wu Long Road, Shanghai, Xuhui District Patentee before: Shanghai Yesbio Bio-Tech Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Method for Detecting Specific Antibodies Against Mycobacterium tuberculosis Lipid Aramannan Granted publication date: 20170510 Pledgee: The Bank of Shanghai branch Caohejing Limited by Share Ltd. Pledgor: VENTURE BIOTECHNOLOGY CO.,LTD. Registration number: Y2024980005346 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |